The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Parkinson’s Disease
Abstract
Parkinson’s disease is a multisystem neurodegenerative disorder with motor and prominent, sometimes premonitory, nonmotor symptoms. Detection of gene variants may inform prognosis and, potentially, treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MDS clinical diagnostic criteria for Parkinson’s disease
Postuma, R. B., Berg, D., Stern, M., Poewe, W., Olanow, C. W., Oertel, W., Obeso, J., Marek, K., Litvan, I., Lang, A. E., et al. (2015) · Movement Disorders · doi:10.1002/mds.26424 · Cited by 7,653
Clinical diagnostic criteria for dementia associated with Parkinson’s disease
Emre, M., Aarsland, D., Brown, R., Burn, D. J., Duyckaerts, C., Mizuno, Y., Broe, G. A., Cummings, J., Dickson, D. W., Gauthier, S., et al. (2007) · Movement Disorders · doi:10.1002/mds.21507 · Cited by 3,027
Dorsey, E. R., Elbaz, A., Nichols, E., Abbasi, N., Abd-Allah, F., Abdelalim, A., Adsuar, J. C., Ansha, M. G., Brayne, C., Choi, J.-Y. J., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30295-3 · Cited by 2,816
Litvan, I., Goldman, J. G., Tröster, A. I., Schmand, B. A., Weintraub, D., Petersen, R. C., Mollenhauer, B., Adler, C. H., Marder, K., Williams‐Gray, C. H., et al. (2012) · Movement Disorders · doi:10.1002/mds.24893 · Cited by 2,609
Transplantation of Embryonic Dopamine Neurons for Severe Parkinson's Disease
Freed, C. R., Greene, P. E., Breeze, R. E., Tsai, W.-Y., DuMouchel, W., Kao, R., Dillon, S., Winfield, H., Culver, S., Trojanowski, J. Q., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441002 · Cited by 2,366
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
Höglinger, G. U., Respondek, G., Stamelou, M., Kurz, C., Josephs, K. A., Lang, A. E., Mollenhauer, B., Müller, U., Nilsson, C., Whitwell, J. L., et al. (2017) · Movement Disorders · doi:10.1002/mds.26987 · Cited by 2,359
Lang, A. E., & Lozano, A. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810083391506 · Cited by 1,994
Incidence of Parkinson's Disease: Variation by Age, Gender, and Race/Ethnicity
Van Den Eeden, S. K. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg068 · Cited by 1,747
Rotenone, Paraquat, and Parkinson’s Disease
Tanner, C. M., Kamel, F., Ross, G. W., Hoppin, J. A., Goldman, S. M., Korell, M., Marras, C., Bhudhikanok, G. S., Kasten, M., Chade, A. R., et al. (2011) · Environmental Health Perspectives · doi:10.1289/ehp.1002839 · Cited by 1,475
Self-citationNeurostimulation for Parkinson's Disease with Early Motor Complications
Schuepbach, W. M. M., Rau, J., Knudsen, K., Volkmann, J., Krack, P., Timmermann, L., Hälbig, T. D., Hesekamp, H., Navarro, S. M., Meier, N., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205158 · Cited by 1,430
Inflammation and immune dysfunction in Parkinson disease
Tansey, M. G., Wallings, R. L., Houser, M. C., Herrick, M. K., Keating, C. E., & Joers, V. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-022-00684-6 · Cited by 1,382
Lang, A. E., & Lozano, A. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810153391607 · Cited by 1,201
The genetic architecture of Parkinson's disease
Blauwendraat, C., Nalls, M. A., & Singleton, A. B. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30287-x · Cited by 1,114
Update on treatments for nonmotor symptoms of Parkinson's disease—an evidence‐based medicine review
Seppi, K., Ray Chaudhuri, K., Coelho, M., Fox, S. H., Katzenschlager, R., Perez Lloret, S., Weintraub, D., Sampaio, C., & and the collaborators of the Parkinson's Disease Update on Non‐Motor Symptoms Study Group on behalf of the Movement Disorders Society Evidence‐Based Medicine Committee (2019) · Movement Disorders · doi:10.1002/mds.27602 · Cited by 1,007
Fox, S. H., Katzenschlager, R., Lim, S., Barton, B., de Bie, R. M. A., Seppi, K., Coelho, M., Sampaio, C., & on behalf of the Movement Disorder Society Evidence‐Based Medicine Committee (2018) · Movement Disorders · doi:10.1002/mds.27372 · Cited by 1,002
Neuropathological assessment of Parkinson’s disease: refining the diagnostic criteria
Dickson, D. W., Braak, H., Duda, J. E., Duyckaerts, C., Gasser, T., Halliday, G. M., Hardy, J., Leverenz, J. B., Del Tredici, K., Wszolek, Z. K., et al. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70238-8 · Cited by 972
A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease
Olanow, C. W., Rascol, O., Hauser, R., Feigin, P. D., Jankovic, J., Lang, A., Langston, W., Melamed, E., Poewe, W., Stocchi, F., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809335 · Cited by 901
The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy
Wenning, G. K., Stankovic, I., Vignatelli, L., Fanciulli, A., Calandra‐Buonaura, G., Seppi, K., Palma, J., Meissner, W. G., Krismer, F., Berg, D., et al. (2022) · Movement Disorders · doi:10.1002/mds.29005 · Cited by 833
Update of the MDS research criteria for prodromal Parkinson's disease
Heinzel, S., Berg, D., Gasser, T., Chen, H., Yao, C., Postuma, R. B., & the MDS Task Force on the Definition of Parkinson's Disease (2019) · Movement Disorders · doi:10.1002/mds.27802 · Cited by 768
Risk of dementia in Parkinson’s disease: A community-based, prospective study
Aarsland, D., Andersen, K., Larsen, J. P., Lolk, A., Nielsen, H., & Kragh–Sørensen, P. (2001) · Neurology · doi:10.1212/wnl.56.6.730 · Cited by 721
Siderowf, A., Concha-Marambio, L., Lafontant, D.-E., Farris, C. M., Ma, Y., Urenia, P. A., Nguyen, H., Alcalay, R. N., Chahine, L. M., Foroud, T., et al. (2023) · The Lancet Neurology · doi:10.1016/s1474-4422(23)00109-6 · Cited by 719
Self-citationCurrent and projected future economic burden of Parkinson’s disease in the U.S.
Yang, W., Hamilton, J. L., Kopil, C., Beck, J. C., Tanner, C. M., Albin, R. L., Ray Dorsey, E., Dahodwala, N., Cintina, I., Hogan, P., et al. (2020) · npj Parkinson's Disease · doi:10.1038/s41531-020-0117-1 · Cited by 657
Self-citationSimuni, T., Chahine, L. M., Poston, K., Brumm, M., Buracchio, T., Campbell, M., Chowdhury, S., Coffey, C., Concha-Marambio, L., Dam, T., et al. (2024) · The Lancet Neurology · doi:10.1016/s1474-4422(23)00405-2 · Cited by 629
Self-citationA biological classification of Parkinson's disease: the SynNeurGe research diagnostic criteria
Höglinger, G. U., Adler, C. H., Berg, D., Klein, C., Outeiro, T. F., Poewe, W., Postuma, R., Stoessl, A. J., & Lang, A. E. (2024) · The Lancet Neurology · doi:10.1016/s1474-4422(23)00404-0 · Cited by 549
Deep-Brain Stimulation for Parkinson's Disease
Okun, M. S. (2012) · New England Journal of Medicine · doi:10.1056/nejmct1208070 · Cited by 541
Trial of Prasinezumab in Early-Stage Parkinson’s Disease
Pagano, G., Taylor, K. I., Anzures-Cabrera, J., Marchesi, M., Simuni, T., Marek, K., Postuma, R. B., Pavese, N., Stocchi, F., Azulay, J.-P., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2202867 · Cited by 421
Bond, A. E., Shah, B. B., Huss, D. S., Dallapiazza, R. F., Warren, A., Harrison, M. B., Sperling, S. A., Wang, X.-Q., Gwinn, R., Witt, J., et al. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2017.3098 · Cited by 373
Trial of Lixisenatide in Early Parkinson’s Disease
Meissner, W. G., Remy, P., Giordana, C., Maltête, D., Derkinderen, P., Houéto, J.-L., Anheim, M., Benatru, I., Boraud, T., Brefel-Courbon, C., et al. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2312323 · Cited by 369
Trial of Cinpanemab in Early Parkinson’s Disease
Lang, A. E., Siderowf, A. D., Macklin, E. A., Poewe, W., Brooks, D. J., Fernandez, H. H., Rascol, O., Giladi, N., Stocchi, F., Tanner, C. M., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2203395 · Cited by 351
Self-citationParkinson’s disease risk from ambient exposure to pesticides
Wang, A., Costello, S., Cockburn, M., Zhang, X., Bronstein, J., & Ritz, B. (2011) · European Journal of Epidemiology · doi:10.1007/s10654-011-9574-5 · Cited by 349
Incidence of Parkinson disease in North America
Willis, A. W., Roberts, E., Beck, J. C., Fiske, B., Ross, W., Savica, R., Van Den Eeden, S. K., Tanner, C. M., Marras, C., on behalf of the Parkinson’s Foundation P4 Group, et al. (2022) · npj Parkinson's Disease · doi:10.1038/s41531-022-00410-y · Cited by 341
Self-citationThe future of stem cell therapies for Parkinson disease
Parmar, M., Grealish, S., & Henchcliffe, C. (2020) · Nature Reviews Neuroscience · doi:10.1038/s41583-019-0257-7 · Cited by 306
Pringsheim, T., Day, G. S., Smith, D. B., Rae-Grant, A., Licking, N., Armstrong, M. J., de Bie, R. M. A., Roze, E., Miyasaki, J. M., Hauser, R. A., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000012868 · Cited by 205
Skin Biopsy Detection of Phosphorylated α-Synuclein in Patients With Synucleinopathies
Gibbons, C. H., Levine, T., Adler, C., Bellaire, B., Wang, N., Stohl, J., Agarwal, P., Aldridge, G. M., Barboi, A., Evidente, V. G. H., et al. (2024) · JAMA · doi:10.1001/jama.2024.0792 · Cited by 197
Deuschl, G., Antonini, A., Costa, J., Śmiłowska, K., Berg, D., Corvol, J., Fabbrini, G., Ferreira, J., Foltynie, T., Mir, P., et al. (2022) · Movement Disorders · doi:10.1002/mds.29066 · Cited by 190
Accuracy of clinical diagnosis of dementia with Lewy bodies: a systematic review and meta-analysis
Rizzo, G., Arcuti, S., Copetti, M., Alessandria, M., Savica, R., Fontana, A., Liguori, R., & Logroscino, G. (2018) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-316844 · Cited by 176
α-Synuclein Seed Amplification Assays for Diagnosing Synucleinopathies: The Way Forward
Bellomo, G., Luca, C. M. G. D., Paoletti, F. P., Gaetani, L., Moda, F., & Parnetti, L. (2022) · Neurology · doi:10.1212/wnl.0000000000200878 · Cited by 175
Trial of Globus Pallidus Focused Ultrasound Ablation in Parkinson’s Disease
Krishna, V., Fishman, P. S., Eisenberg, H. M., Kaplitt, M., Baltuch, G., Chang, J. W., Chang, W.-C., Martinez Fernandez, R., del Alamo, M., Halpern, C. H., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2202721 · Cited by 163
Concomitant pathologies among a spectrum of parkinsonian disorders
Dugger, B. N., Adler, C. H., Shill, H. A., Caviness, J., Jacobson, S., Driver-Dunckley, E., & Beach, T. G. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.02.012 · Cited by 161
The cell biology of Parkinson’s disease
Panicker, N., Ge, P., Dawson, V. L., & Dawson, T. M. (2021) · Journal of Cell Biology · doi:10.1083/jcb.202012095 · Cited by 159
Rizig, M., Bandres-Ciga, S., Makarious, M. B., Ojo, O. O., Crea, P. W., Abiodun, O. V., Levine, K. S., Abubakar, S. A., Achoru, C. O., Vitale, D., et al. (2023) · The Lancet Neurology · doi:10.1016/s1474-4422(23)00283-1 · Cited by 159
Domingo, A., & Klein, C. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63233-3.00014-2 · Cited by 152
Trial of pimavanserin in dementia-related psychosis
Tariot, P. N., Cummings, J. L., Soto-Martin, M. E., Ballard, C., Erten-Lyons, D., Sultzer, D. L., Devanand, D. P., Weintraub, D., McEvoy, B., Youakim, J. M., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2034634 · Cited by 145
Concordance for Parkinson's disease in twins: A 20‐year update
Goldman, S. M., MAREK, K. L., Ottman, R., Meng, C., Comyns, K., Chan, P., Ma, J., Marras, C., Langston, J. W., Ross, G. W., et al. (2019) · Annals of Neurology · doi:10.1002/ana.25441 · Cited by 123
Self-citationPharmacological Treatment of Tremor in Parkinson’s Disease Revisited
Pirker, W., Katzenschlager, R., Hallett, M., & Poewe, W. H. (2023) · Journal of Parkinson s Disease · doi:10.3233/jpd-225060 · Cited by 120
ParkinsonNet: A Low-Cost Health Care Innovation With A Systems Approach From The Netherlands
Bloem, B. R., Rompen, L., de Vries, N. M., Klink, A., Munneke, M., & Jeurissen, P. (2017) · Health Affairs · doi:10.1377/hlthaff.2017.0832 · Cited by 119
Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2023 Update
McFarthing, K., Buff, S., Rafaloff, G., Fiske, B. K., Mursaleen, L., Fuest, R., Wyse, R. K. H., & Stott, S. (2023) · Journal of Parkinson s Disease · doi:10.3233/jpd-239901 · Cited by 108
Using a smartwatch and smartphone to assess early Parkinson’s disease in the WATCH-PD study
Adams, J. L., Kangarloo, T., Tracey, B., O’Donnell, P., Volfson, D., Latzman, R. D., Zach, N., Alexander, R., Bergethon, P., Cosman, J., et al. (2023) · npj Parkinson's Disease · doi:10.1038/s41531-023-00497-x · Cited by 98
Self-citationBega, D., Kuo, P., Chalkidou, A., Grzeda, M., Macmillan, T., Brand, C., Sheikh, Z., & Antonini, A. (2021) · npj Parkinson's Disease · doi:10.1038/s41531-021-00185-8 · Cited by 97
Risk of Parkinson Disease Among Service Members at Marine Corps Base Camp Lejeune
Goldman, S. M., Weaver, F. M., Stroupe, K. T., Cao, L., González, B., Colletta, K., Brown, E. G., & Tanner, C. M. (2023) · JAMA Neurology · doi:10.1001/jamaneurol.2023.1168 · Cited by 89
Self-citationReproducibility of data-driven Parkinson's disease subtypes for clinical research
Mestre, T., Eberly, S. W., Tanner, C. M., Grimes, D., Lang, A. E., Oakes, D., & Marras, C. (2018) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2018.07.009 · Cited by 87
Self-citationClinical Diagnostic Accuracy of Early/Advanced Parkinson Disease: An Updated Clinicopathologic Study
Adler, C. H., Beach, T. G., Zhang, N., Shill, H. A., Driver‐Dunckley, E. D., Mehta, S. H., Atri, A., Caviness, J. N., Serrano, G. E., Shprecher, D., et al. (2020) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000001016 · Cited by 58
Zhang, X., Molsberry, S. A., Schwarzschild, M. A., Ascherio, A., & Gao, X. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.27738 · Cited by 49
Cubo, E., & López, P. D. D. (2022) · Brain Sciences · doi:10.3390/brainsci12121735 · Cited by 48
Gene–Environment Interactions for Parkinson's Disease
Reynoso, A., Torricelli, R., Jacobs, B. M., Shi, J., Aslibekyan, S. W., Norcliffe‐Kaufmann, L., Noyce, A. J., & Heilbron, K. (2023) · Annals of Neurology · doi:10.1002/ana.26852 · Cited by 47
Cognitive behavioral therapy improves diverse profiles of depressive symptoms in Parkinson's disease
Dobkin, R. D., Mann, S., Interian, A., Gara, M. A., & Menza, M. A. (2019) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5077 · Cited by 40
Path to Parkinson Disease Prevention
Berg, D., Crotty, G. F., Keavney, J. L., Schwarzschild, M. A., Simuni, T., & Tanner, C. M. (2022) · Neurology · doi:10.1212/wnl.0000000000200793 · Cited by 34
Self-citationAssociation of brain heptachlor epoxide and other organochlorine compounds with lewy pathology
Ross, G. W., Abbott, R. D., Petrovitch, H., Duda, J. E., Tanner, C. M., Zarow, C., Uyehara‐Lock, J. H., Masaki, K., Launer, L. J., Studabaker, W. B., et al. (2018) · Movement Disorders · doi:10.1002/mds.27594 · Cited by 32
Self-citationTraumatic brain injury preceding clinically diagnosed α-synucleinopathies: A case-control study
Hasan, S., Mielke, M. M., Turcano, P., Ahlskog, J. E., Bower, J. H., & Savica, R. (2020) · Neurology · doi:10.1212/wnl.0000000000008995 · Cited by 16
Association of Lewy Bodies With Age-Related Clinical Characteristics in Black and White Decedents
Nag, S., Barnes, L. L., Yu, L., Buchman, A. S., Bennett, D. A., Schneider, J. A., & Wilson, R. S. (2021) · Neurology · doi:10.1212/wnl.0000000000012324 · Cited by 16
Maiti, B., & Perlmutter, J. S. (2023) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000001210 · Cited by 9
Cited by
Chronic stress induces depression-like behaviors and Parkinsonism via upregulating α-synuclein
Xia, D., Xiong, M., Yang, Y., Wang, X., Chen, Q., Li, S., Meng, L., & Zhang, Z. (2025) · npj Parkinson's Disease · doi:10.1038/s41531-025-00998-x · Cited by 15
Hermann, D. M., Bacigaluppi, M., Bassetti, C. L., Bassotti, G., Boltze, J., Chan, A., Dalkara, T., Denes, A., Diez-Tejedor, E., Dodel, R., et al. (2025) · Exploration of Neuroscience · doi:10.37349/en.2025.1006106 · Cited by 13
Metadata
- Authors
- Tanner, C. M., & Ostrem, J. L.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2024-08
- Volume
- 391
- Issue
- 5
- Pages
- 442-452
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W4401163271
- Cited by
- 382
- References
- 61
- FWCI
- 87.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.